Health AI Central
Peer-Reviewed Publication
Genet Med2026;102731.September 22, 2026Journal Article

Assessing Melanoma and Pancreatic Cancer Risks in Diverse CDKN2A Heterozygote Populations.

Colin C Young1, Magan Trottier2, Carolyn Horton2, Maggie Feng3, Amal Yussuf2, Jacqueline Mersch4, Amber Gemmell4, Andrew Giles2, Linda M Polfus2, Marcy E Richardson2
1Ambry Genetics, Aliso Viejo, California. Electronic address: cyoung@ambrygen.com.
2Ambry Genetics, Aliso Viejo, California.
3WCG Statistics Collaborative, Cary, North Carolina.
4University of Texas Southwestern Medical Center, Dallas, Texas.
PubMed DOI

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.